Scynexis (SCYX) Misses Q2 EPS by 4c

Scynexis (NASDAQ: SCYX) reported Q2 EPS of ($0.56), $0.04 worse than the analyst estimate of ($0.52).

Cash, cash equivalents and short-term investments totaled $50.3 million as of June 30, 2016, with net working capital of $48.2 million.

For earnings history and earnings-related data on Scynexis (SCYX) click here.

You May Also Be Interested In

• SCYNEXIS (SCYX) PT Raised to $33 at Guggenheim
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c